Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 116
Filter
1.
BMC Gastroenterol ; 20(1): 7, 2020 Jan 13.
Article in English | MEDLINE | ID: mdl-31931737

ABSTRACT

BACKGROUND: The anti-immunological rejection therapy for small-for-size syndrome (SFSS) after live donor liver transplantation (LDLT) play a central role in keeping graft survival. The hepatocyte number and grafts function has undergone real-time changes with the proliferation and apoptosis of the grafts after reperfusion. Lacking an accurate and effective treatment regiments or indicators to guide the use of immunosuppressive drugs in SFS liver transplantation has made immunotherapy after SFS liver transplantation an urgent problem to be solved. Herein, we established small-for-size (SFS) and normal size liver transplantation model in rats to explore the effective indicators in guiding immunotherapy, to find an effective way for overcoming SFSS. METHODS: Lewis rats (donors) and BN rats (recipients) were used to mimic allograft liver transplantation and treated with tacrolimus. Local graft immune response was analyzed through haematoxylin and eosin and immunohistochemistry. Flow cytometry was used to assess the overall immune status of recipient. The pharmacokinetics mechanism of immunosuppressive drugs was explored through detecting CYP3A2 expression at mRNA level and protein levels. RESULTS: The results showed the local immune reaction of SFS grafts and systemic immune responses of recipient were significantly increased compared with those in normal size grafts and their recipient at four days after liver transplantation. Regression equation was used to regulate the tacrolimus dose which not only controlled tacrolimus serum concentration effectively but alleviated liver damage and improved survival rate. CONCLUSIONS: This study showed that AST level and tacrolimus serum concentrations are effective indicators in guiding immunotherapy. Regression equation (TD = - 0.494TC-0.0035AST + 260.487) based on AST and tacrolimus serum concentration can be used as a reference for adjustment of immunotherapy after SFS liver transplantation, which is applicable in clinical practice.


Subject(s)
Graft Rejection/drug therapy , Graft Survival/immunology , Immunosuppressive Agents/therapeutic use , Liver Transplantation/adverse effects , Tacrolimus/therapeutic use , Animals , Aspartate Aminotransferases/blood , Immunosuppressive Agents/blood , Liver/immunology , Liver Transplantation/methods , Living Donors , Organ Size/immunology , Rats , Rats, Inbred BN , Rats, Inbred Lew , Tacrolimus/blood , Transplants/immunology , Treatment Outcome
2.
Theriogenology ; 141: 211-218, 2020 Jan 01.
Article in English | MEDLINE | ID: mdl-31387698

ABSTRACT

Castration reduces aggressive and sexual behaviour and provides better carcass quality in bull calves. Vaccination against gonadotrophin-releasing hormone (GnRH) is used as an alternative to surgical castration for the purposes of reducing pain and distress in the animals. Currently, no anti-GnRH vaccine has been authorized for use in cattle in the European Union. The aim of the present study was to assess the effect of an anti-GnRH swine-specific vaccine (Improvac®, Zoetis, USA) on the morphology, structure and function of bull testes. Animals were vaccinated at days 1, 21 and 104 of the experimental period and were classified based on their live weight into the following two groups: LIGHT (172.9 ±â€¯30.00 kg) and HEAVY (323.8 ±â€¯37.79 kg). The scrotal circumference was measured on day 1 and prior to slaughter (day 164). At slaughter, the sperm motility and concentration in the caudae epididymis were assessed. Testes were weighed, measured and examined using ultrasound, and then tissue samples were collected and fixed in formalin. Histological and immunohistochemical studies were performed on the testes to measure the diameter of the seminiferous tubules and assess the testicular cell populations. The results revealed that suppression of testicular development was associated with the use of the Improvac® vaccine, which resulted in a smaller size of the testes and impaired spermatid production. However, the effect of Improvac® was more pronounced and consistent in calves vaccinated at a low live weight than at a heavy live weight, which suggested that vaccination is more effective when calves are vaccinated before or early during puberty. However, testes from calves vaccinated at a low live weight were more prone to the development of intraluminal concretions in the seminiferous tubules.


Subject(s)
Gonadotropin-Releasing Hormone/immunology , Orchiectomy/methods , Testis/anatomy & histology , Vaccines, Contraceptive/immunology , Animals , Cattle , Male , Organ Size/immunology , Scrotum/anatomy & histology , Spermatozoa/physiology , Vaccination
3.
Exp Parasitol ; 207: 107789, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31669169

ABSTRACT

American visceral leishmaniasis is caused by the protozoan Leishmania infantum. The control of the disease depends on the magnitude of the Th1 cell response and IL-10 producing regulatory T cells. Administration of chemokine, such as CXCL10, has shown promising results in the leishmaniasis treatment. Previous studies from our group have shown that CXCL10 induces a reduction in parasite burden in the spleen and a decrease in IL-10 and TGF-ß production in L. infantum-infected BALB/c mice. This work investigated whether CXCL10-treatment reduces IL-10 + Treg cell populations (CD4+CD25+Foxp3+ and Tr1) and induces morphological changes in the spleen. BALB/c mice were infected and treated or not with CXCL10 on the 1st, 3rd and 7th days of infection. CXCL10-treatment was able to reduce the parasite load in the spleen in L. infantum-infected BALB/c mice and this decrease in the number of parasites correlated with the decrease in size of this organ in treated animals compared to untreated animals. 7, 23, and 45 days post-treatment (p.t.), the phenotype and frequency of IL-10 + Treg cells were evaluated by flow cytometry, and the morphological changes of the spleen were analyzed by optical microscopy. After 7 and 23 days p.t., CXCL10-treated animals showed a significant reduction of CD25-Foxp3-IL-10+ (Tr1) cells in the spleen when compared to untreated animals, whereas CD4+CD25+Foxp3+IL-10+ Treg cells reduced later at 23rd and 45th days p.t. Furthermore, while untreated animals showed a significant positive correlation between IL-10 production and Tr1 cells, in CXCL10-treated group this correlation was negative. Thus, these findings show that treatment with CXCL10 chemokine in L. infantum-infected BALB/c mice results in suppression of IL10+ Treg (Foxp3+ and Tr1) cells in the spleen, associated with a reduction in parasite load and splenomegaly.


Subject(s)
Chemokine CXCL10/therapeutic use , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/immunology , Spleen/immunology , T-Lymphocytes, Regulatory/drug effects , Adjuvants, Immunologic/therapeutic use , Animals , Chemokine CXCL10/administration & dosage , Chemokine CXCL10/pharmacology , Cricetinae , Flow Cytometry , Forkhead Transcription Factors/immunology , Humans , Injections, Intraperitoneal , Leishmania infantum/drug effects , Leishmania infantum/immunology , Leishmania infantum/pathogenicity , Male , Mesocricetus , Mice , Mice, Inbred BALB C , Organ Size/drug effects , Organ Size/immunology , Parasite Load , Spleen/parasitology , Spleen/pathology , T-Lymphocytes, Regulatory/immunology , Virulence
4.
Bull Exp Biol Med ; 167(5): 624-627, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31606806

ABSTRACT

We studied the effect of LPS on the state of stress-marker organs in rats at various periods after a single exposure to long-term stress on the model of 24-h immobilization. The animals were intraperitoneally injected with LPS in a dose of 100 µg/kg immediately after the negative emotiogenic exposure. Changes in physiological parameters were evaluated 3 h, 1 day, and 8 days after immune stimulation. Acute stress was accompanied by a decrease in the weight of the thymus during all stages of the post-stress period. An increase in the relative weight of theadrenal glands in animals under these conditions was observed only on day 8 after restraint stress. The induction of immune reactions due to systemic treatment with LPS was shown to prevent involution of the spleen in the late stage after a single exposure to long-term stress (day 8). Hypertrophy of the adrenal glands, which serves as one of the typical reactions of mammals to negative emotiogenic factors, was not revealed during the post-stress period after antigenic stimulation. These data hold much promise for the development of new approaches to the use of immunoactive substances to prevent or reduce the severity of physiological changes after emotiogenic loads.


Subject(s)
Adrenal Glands/drug effects , Immunity, Innate/drug effects , Lipopolysaccharides/pharmacology , Stress, Psychological/physiopathology , Thymus Gland/drug effects , Adrenal Glands/physiopathology , Animals , Immobilization/methods , Injections, Intraperitoneal , Male , Organ Size/drug effects , Organ Size/immunology , Rats , Rats, Wistar , Spleen/drug effects , Spleen/physiopathology , Stress, Psychological/immunology , Stress, Psychological/prevention & control , Thymus Gland/physiopathology
5.
Nat Commun ; 10(1): 3031, 2019 07 10.
Article in English | MEDLINE | ID: mdl-31292453

ABSTRACT

Maternal immune dysregulation seems to affect fetal or postnatal immune development. Preeclampsia is a pregnancy-associated disorder with an immune basis and is linked to atopic disorders in offspring. Here we show reduction of fetal thymic size, altered thymic architecture and reduced fetal thymic regulatory T (Treg) cell output in preeclamptic pregnancies, which persists up to 4 years of age in human offspring. In germ-free mice, fetal thymic CD4+ T cell and Treg cell development are compromised, but rescued by maternal supplementation with the intestinal bacterial metabolite short chain fatty acid (SCFA) acetate, which induces upregulation of the autoimmune regulator (AIRE), known to contribute to Treg cell generation. In our human cohorts, low maternal serum acetate is associated with subsequent preeclampsia, and correlates with serum acetate in the fetus. These findings suggest a potential role of acetate in the pathogenesis of preeclampsia and immune development in offspring.


Subject(s)
Acetates/blood , Fetus/immunology , Pre-Eclampsia/immunology , Prenatal Exposure Delayed Effects/immunology , T-Lymphocytes, Regulatory/immunology , Acetates/administration & dosage , Acetates/immunology , Acetates/metabolism , Adult , Animals , Animals, Newborn , Case-Control Studies , Child Development , Child, Preschool , Dietary Supplements , Female , Fetus/cytology , Fetus/diagnostic imaging , Gastrointestinal Microbiome/immunology , Germ-Free Life/immunology , Humans , Immune Tolerance/immunology , Infant , Infant, Newborn , Longitudinal Studies , Maternal-Fetal Exchange/immunology , Mice , Organ Size/immunology , Pre-Eclampsia/blood , Pre-Eclampsia/diagnosis , Pregnancy , Prenatal Exposure Delayed Effects/pathology , Prenatal Exposure Delayed Effects/prevention & control , Prospective Studies , Thymus Gland/cytology , Thymus Gland/diagnostic imaging , Thymus Gland/growth & development , Thymus Gland/immunology , Transcription Factors/immunology , Transcription Factors/metabolism , Ultrasonography, Prenatal , Young Adult , AIRE Protein
6.
Front Immunol ; 10: 937, 2019.
Article in English | MEDLINE | ID: mdl-31134061

ABSTRACT

Syk is a non-receptor tyrosine kinase critically involved in signaling by various immunoreceptors including B-cell-receptors and activating Fc-receptors. We have previously shown that Syk also mediates immunoreceptor-like signals required for the in vitro development and function of osteoclasts. However, the perinatal lethality of Syk-/- mice precluded the analysis of the role of Syk in in vivo bone metabolism. To overcome that problem, we generated mice with osteoclast-specific (SykΔOC ) or hematopoietic (SykΔHaemo ) Syk deficiency by conditional deletion of Syk using Cre recombinase expressed under the control of the Ctsk or Vav1 promoter, respectively. Micro-CT analysis revealed increased bone trabecular density in both SykΔOC and SykΔHaemo mice, although hematopoietic Syk deficiency caused a more severe phenotype than osteoclast-specific Syk deficiency. Osteoclast-specific Syk deficiency reduced, whereas hematopoietic Syk deficiency completely blocked in vitro development of osteoclasts. Both interventions inhibited the resorptive activity of osteoclasts and osteoclast-specific gene expression. Kinetic analysis of Syk protein levels, Cre expression and the genomic deletion of the Sykflox allele revealed complete and early deletion of Syk from SykΔHaemo osteoclasts whereas Syk was incompletely deleted at a later stage of osteoclast development from SykΔOC cultures. Those results provide an explanation for the in vivo and in vitro difference between the SykΔOC and SykΔHaemo mutant strains and suggest late activation of, and incomplete target gene deletion upon, osteoclast-specific Cre expression driven by the Ctsk promoter. Taken together, our results indicate that Syk plays an indispensable role in osteoclast-mediated in vivo bone resorption and suggest that Syk-specific inhibitors may provide therapeutic benefit in inflammatory and other diseases characterized by excessive osteoclast-mediated bone resorption.


Subject(s)
Bone Resorption/immunology , Bone and Bones/immunology , Gene Deletion , Hematopoietic Stem Cells/immunology , Osteoclasts/immunology , Syk Kinase/deficiency , Animals , Bone Resorption/genetics , Bone Resorption/pathology , Bone and Bones/pathology , Hematopoietic Stem Cells/pathology , Mice , Mice, Transgenic , Organ Size/genetics , Organ Size/immunology , Osteoclasts/pathology , Syk Kinase/immunology
7.
Sci Rep ; 8(1): 16370, 2018 11 06.
Article in English | MEDLINE | ID: mdl-30401976

ABSTRACT

Marek's Disease Virus (MDV) is the causative agent of a lymphoproliferative disease, Marek's disease (MD) in chickens. MD is only controlled by mass vaccination; however, immunity induced by MD vaccines is unable to prevent MDV replication and transmission. The herpesvirus of turkey (HVT) vaccine is one of the most widely used MD vaccines in poultry industry. Vaccines can be adjuvanted with Toll-like receptor ligands (TLR-Ls) to enhance their efficacy. In this study, we examined whether combining TLR-Ls with HVT can boost host immunity against MD and improve its efficacy. Results demonstrated that HVT alone or HVT combined with encapsulated CpG-ODN partially protected chickens from tumor incidence and reduced virus replication compared to the control group. However, encapsulated CpG-ODN only moderately, but not significantly, improved HVT efficacy and reduced tumor incidence from 53% to 33%. Further investigation of cytokine gene profiles in spleen and bursa of Fabricius revealed an inverse association between interleukin (IL)-10 and IL-18 expression and protection conferred by different treatments. In addition, the results of this study raise the possibility that interferon (IFN)-ß and IFN-γ induced by the treatments may exert anti-viral responses against MDV replication in the bursa of Fabricius at early stage of MDV infection in chickens.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/metabolism , Marek Disease Vaccines/immunology , Marek Disease Vaccines/metabolism , Toll-Like Receptors/metabolism , Animals , Chickens , Cytokines/genetics , Feathers/metabolism , Gene Dosage , Gene Expression Regulation/immunology , Ligands , Marek Disease Vaccines/genetics , Organ Size/immunology
8.
Front Immunol ; 9: 2523, 2018.
Article in English | MEDLINE | ID: mdl-30443254

ABSTRACT

Fetal growth restriction (FGR) causes a wide variety of defects in the neonate which can lead to increased risk of heart disease, diabetes, anxiety and other disorders later in life. However, the effect of FGR on the immune system, is poorly understood. We used a well-characterized mouse model of FGR in which placental Igf-2 production is lost due to deletion of the placental specific Igf-2 P0 promotor. The thymi in such animals were reduced in mass with a ~70% reduction in cellularity. We used single cell RNA sequencing (Drop-Seq) to analyze 7,264 thymus cells collected at postnatal day 6. We identified considerable heterogeneity among the Cd8/Cd4 double positive cells with one subcluster showing marked upregulation of transcripts encoding a sub-set of proteins that contribute to the surface of the ribosome. The cells from the FGR animals were underrepresented in this cluster. Furthermore, the distribution of cells from the FGR animals was skewed with a higher proportion of immature double negative cells and fewer mature T-cells. Cell cycle regulator transcripts also varied across clusters. The T-cell deficit in FGR mice persisted into adulthood, even when body and organ weights approached normal levels due to catch-up growth. This finding complements the altered immunity found in growth restricted human infants. This reduction in T-cellularity may have implications for adult immunity, adding to the list of adult conditions in which the in utero environment is a contributory factor.


Subject(s)
Fetal Growth Retardation/immunology , Thymus Gland/immunology , Animals , Animals, Newborn , Disease Models, Animal , Female , Insulin-Like Growth Factor II/immunology , Male , Mice , Mice, Inbred C57BL , Organ Size/immunology , Placenta/immunology , Pregnancy , Single-Cell Analysis/methods
9.
Eur J Pharmacol ; 824: 57-63, 2018 Apr 05.
Article in English | MEDLINE | ID: mdl-29382533

ABSTRACT

Psoriasis is a chronic auto-immune inflammation disease with skin lesions and abnormal keratinocyte proliferation. Sunitinib, a multi-targeted tyrosine kinase inhibitor, is known to selectively inhibit several growth factor receptors, including vascular endothelial growth factor receptor, platelet-derived growth factor receptor and stem cell factor. It was reported that a patient with renal cell carcinoma (RCC) whose psoriatic lesion was resolved dramatically during treatment with Sunitinib, however, the mechanism is still unclear. We applied Sunitinib ointment to treat imiquimod-induced mouse model of psoriasis and found that Sunitinib ointment could alleviate imiquimod-induced psoriasis-like inflammation and reduce the Ki67 expression, while Sunitinib ointment couldn't reduce imiquimod-induced splenomegaly of the mouse model, then we concentrated on studying the effect of Sunitinib on the proliferation and apoptosis of keratinocytes, we cultivated HaCaT cells with epidermal growth factor (HaCaT/E cells) to represent as a state of highly proliferative psoriatic keratinocytes. We found that Sunitinib could inhibit the proliferation of Hacat/E cell in a time and concentration dependent manner by influencing the expression level of cell cycle protein D1, cycle protein E1, in addition, Sunitinib could induce the apoptosis of Hacat/E cell and up-regulate the expression of poly ADP-ribose polymerase (PARP). Sunitinib down-regulated the expression of phosphorylated signal transduction and activator of transcription 3 (p-Stat3) of Hacat/E cells significantly. We conclude that Sunitinib alleviates imiquimod-induced psoriasis-like inflammation by regulating the proliferation and apoptosis of HaCaT cells through inhibiting the expression of p-Stat3.


Subject(s)
Apoptosis/drug effects , Indoles/administration & dosage , Indoles/pharmacology , Keratinocytes/drug effects , Keratinocytes/pathology , Psoriasis/drug therapy , Pyrroles/administration & dosage , Pyrroles/pharmacology , Administration, Topical , Animals , Cell Line , Cell Proliferation/drug effects , Down-Regulation/drug effects , Gene Expression Regulation/drug effects , Indoles/therapeutic use , Inflammation/drug therapy , Inflammation/pathology , Keratinocytes/metabolism , Male , Mice , Organ Size/drug effects , Organ Size/immunology , Phosphoproteins/metabolism , Psoriasis/immunology , Psoriasis/metabolism , Psoriasis/pathology , Pyrroles/therapeutic use , STAT3 Transcription Factor/metabolism , Signal Transduction/drug effects , Sunitinib , Vascular Endothelial Growth Factor A/metabolism
11.
Inflammation ; 40(3): 861-870, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28233078

ABSTRACT

The aim of this study is to identify whether vaccinating twice with bladder homogenate can establish a new model of experimental autoimmune cystitis (EAC) in C57BL/6 strain mice. C57BL/6 mice were vaccinated with bladder homogenate in complete Freund's adjuvant (CFA) and boost immunized with bladder homogenate in incomplete Freund's adjuvant (IFA) after 2 weeks were used as the EAC model. Mice immunized with phosphate-buffered saline (PBS) in CFA or IFA were used as the control. Micturition habits and suprapubic-pelvic pain threshold were measured 4 weeks after primary immunization. Bladder to body weight ratios and expression of inflammatory cytokines and neurokinin 1 receptor (NK1R) were then examined. Histologic and immunohistochemical examination of the bladder was carried out, and IL-1ß, IFN-γ, and TNF-α production by the kidneys, liver, and lungs was also tested. Double-immunized mice were extensively sensitive to pressure applied on the pelvic area (P < 0.001). Compared to single-immunized mice or controls, double-immunized mice showed more micturition frequency, lower urine output per micturition, higher bladder to body weight ratio, and significant elevation in the expression of inflammatory cytokines, including IL-1ß, IL-4, IL-6, IL-10, IFN-γ, and TNF-α (all P < 0.05). NK1R gene expression was significantly increased in double-immunized mice compared to the other three groups (P < 0.001). A nonspecific immune response occurred in the liver but was much weaker than bladder inflammation. Our dual immunization EAC model in C57BL/6 mice can effectively mimic the symptoms and pathophysiologic characteristics of BPS/IC and thus can be widely used to investigate the pathogenesis and therapeutic strategies of BPS/IC.


Subject(s)
Cystitis, Interstitial/pathology , Pain/etiology , Urinary Bladder/pathology , Animals , Autoimmune Diseases , Cytokines/analysis , Disease Models, Animal , Immunization/methods , Mice , Mice, Inbred C57BL , Organ Size/immunology , Urination
12.
J Magn Reson Imaging ; 44(5): 1262-1269, 2016 11.
Article in English | MEDLINE | ID: mdl-27079832

ABSTRACT

PURPOSE: To longitudinally evaluate the cortical thickness and deep gray matter structures volume, measured from T1 three-dimensional (3D) Gradient echo-weighted imaging, and white matter integrity, assessed from diffusion tensor imaging (DTI) of HIV-positive patients. MATERIALS AND METHODS: Twenty-one HIV-positive patients on stable highly active antiretroviral therapy (HAART) with CD4+ T lymphocytes count >200 cells/mL and viral load <50 copies/mL underwent two magnetic resonance imaging (MRI) scans with a median interval of 26.6 months. None of the patients had HIV-related dementia. T1 3D magnetization prepared rapid gradient echo-weighted imaging and DTI along 30 noncolinear directions were performed using a 1.5 Tesla MR scanner. FreeSurfer was used to perform cortical volumetric reconstruction and segmentation of deep gray matter structures. For tract-based spatial statistics analysis, a white matter skeleton was created, and a permutation-based inference with 5000 permutations, with a threshold of P < 0.05 was used to identify abnormalities in fractional anisotropy (FA). The median, radial, and axial diffusivities were also projected onto the mean FA skeleton. RESULTS: There were no significant differences in cortical thickness, deep gray matter structures volumes or diffusivity parameters between scans at the two time points (considering P < 0.05). CONCLUSION: No longitudinal differences in cortical thickness, deep gray matter volumes, or white matter integrity were observed in an HIV-positive population on stable HAART, with undetectable viral load and high CD4+ T lymphocytes count. J. Magn. Reson. Imaging 2016;44:1262-1269.


Subject(s)
Diffusion Tensor Imaging/methods , Encephalitis, Viral/drug therapy , Encephalitis, Viral/pathology , Gray Matter/pathology , HIV Infections/drug therapy , HIV Infections/pathology , White Matter/pathology , Adult , Antiretroviral Therapy, Highly Active/methods , Encephalitis, Viral/immunology , Female , Gray Matter/immunology , HIV Infections/immunology , Humans , Longitudinal Studies , Male , Middle Aged , Organ Size/immunology , Treatment Outcome , Viral Load/immunology , White Matter/immunology
13.
Meat Sci ; 116: 8-15, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26835834

ABSTRACT

The present study addressed (1) the levels of boar taint compounds in entire (EM) and immunocastrated (IM) male pigs during their growth, (2) the evolution of testes volume and density and (3) the relationship between physical characteristics of the testes and boar taint compounds. For that purpose 24 EM and 20 IM pigs were CT scanned at several body weights (TBW). After each scanning a subsample of pigs was slaughtered, and subcutaneous fat was collected to determine androstenone and skatole concentration. Additional subsample (n=4/sex) was CT scanned 13 days after the second vaccination (V2). Testes density changes with growth, is different in EM and IM, but is not a reliable marker of the level of boar taint compounds. On the other hand, testes to body volume ratio is a better predictor for androstenone and could provide a good tool at slaughter plants to detect immunocastrated pigs with high boar taint compounds.


Subject(s)
Orchiectomy/veterinary , Sexual Maturation/physiology , Testis/physiology , Tomography, X-Ray Computed/veterinary , Weight Gain , Adipose Tissue/chemistry , Animals , Contraception, Immunologic/methods , Contraception, Immunologic/veterinary , Gonadotropin-Releasing Hormone/immunology , Indoles/analysis , Male , Orchiectomy/methods , Organ Size/immunology , Skatole/analysis , Swine , Testis/anatomy & histology , Testis/immunology
14.
Poult Sci ; 95(3): 518-27, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26740133

ABSTRACT

The effect of organic trace mineral supplementation on performance, intestinal morphology, immune organ weights (bursa of Fabricius and spleen), expression of innate immune response related genes, blood heterophils/lymphocytes ratio, chemical metabolic panel, natural antibodies (IgG), and oxidative stress of broiler chickens was studied. A total of 1,080 day-old male broilers were assigned to 1 of 3 dietary treatments, which included basal diet with Monensin (control), control diet supplemented with bacitracin methylene disalicylate (BMD), and BMD diet supplemented with organic trace minerals (OTM). No difference in feed conversion ratio was observed among treatments; ileum histomorphological analysis showed a lower crypt depth, higher villi height/crypt depth ratio, and lower villi width in the OTM treatment compared to control. Furthermore, OTM treatment resulted in higher uric acid and lower plasma malondehaldehyde (MDA), indicating lower oxidative stress. Gene expression analysis showed that OTM treatment resulted in up-regulations of TLR2 bin the ileum, and TLR2b, TLR4, and IL-12p35 in the bursa of Fabricius, and down-regulation of TLR2b and TLR4 in the cecal tonsils. In the spleen, OTM treatment resulted in up-regulation of IL-10. In conclusion, OTM supplementation to broiler diets may have beneficial effects on intestinal development, immune system status, and survival by improving ileum histomorphological parameters, modulation of Toll-like receptors and anti-inflammatory cytokines, and decreasing level of MDA, which in conjunction could enhance health status.


Subject(s)
Animal Nutritional Physiological Phenomena , Chickens/physiology , Diet/veterinary , Dietary Supplements , Immunity, Innate/immunology , Oxidative Stress/immunology , Animal Feed/analysis , Animals , Antibodies, Heterophile/blood , Chickens/anatomy & histology , Chickens/growth & development , Chickens/immunology , Immune System/growth & development , Immunoglobulin G/blood , Intestines/anatomy & histology , Lymphocyte Count/veterinary , Lymphocytes/immunology , Organ Size/immunology , Trace Elements
15.
Anim Sci J ; 87(2): 284-92, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26419323

ABSTRACT

The effects of environmental enrichment and transport stress on the immune system were investigated in laying hens. A total of 48 1-day-old chickens were used, half of the chickens were reared in conventional cages (RCC) and the rest in enriched cages (REC). Transport stress was applied in the 17th week. Liver weight decreased, spleen and bursa of Fabricius weights, white blood cell count, CD4+ and CD8+ cell proportions increased due to the transport. Environmental enrichment significantly increased antibody production and tended to increase monocyte percentage and CD8+ cell proportion. The effect of transport on, heterophil (H) and lymphocyte (L) percentages was not significant in RCC chickens. While heterophil percentage and H:L ratio increased, lymphocyte percentage decreased in REC chickens subjected to transport. Transport stress increased heterophil functions both in REC and RCC chickens, but the increase was higher in REC hens than in RCC hens. In conclusion, although environmental enrichment did not neutralize the effect of transport on lymphoid organs, it activated the non-specific immune system, cellular and the humoral branches of the specific immune system by increasing heterophil functions, CD8+ cells and antibody production, respectively. Therefore, environmental enrichment suggested for improving animal welfare may also be beneficial to improve the immune system of birds exposed to stress.


Subject(s)
Animal Welfare , Antibodies, Heterophile/immunology , Chickens/immunology , Environment , Immune System/immunology , Immunity, Cellular/immunology , Lymphoid Tissue/immunology , Organ Size/immunology , Stress, Physiological/immunology , Transportation , Animals , CD8-Positive T-Lymphocytes/immunology , Confined Spaces , Female
16.
PLoS One ; 10(3): e0119750, 2015.
Article in English | MEDLINE | ID: mdl-25803644

ABSTRACT

An experiment was conducted to investigate the effects of dietary energy level on the performance and immune function of stressed broiler chickens (Gallus gallus domesticus). A total of 96 three-day-old male broiler chickens (Ross × Ross) were divided into two groups. One group received a high energy (HE) diet and the other group received a low energy (LE) diet for 7 days. At 5 days of age, the chickens from each group were further divided into two sub-groups and received one of the following two treatments for 3 days: (1) subcutaneous injection of corticosterone, twice per day (CORT group; 2 mg of CORT/kg BW in corn oil) and (2) subcutaneous injection of corn oil, twice per day (Control/Sham treatment group). At 10 days of age, samples of blood, duodenum, jejunum, and ileum were obtained. Compared with the other three groups, the LE group treated with CORT had the lowest average daily gain (ADG) and the poorest feed conversion ratio (FCR, P < 0.05). Furthermore, CORT treatment decreased the relative weight (RW) of the bursa independent of the dietary energy level, but it decreased the RW of the thymus only in the chickens fed the LE diet. By contrast, CORT administration decreased the RW of the spleen only in the chickens fed the HE diet (P < 0.05). The plasma total protein, albumin, tumor necrosis factor alpha, interleukin 2 and immunoglobulin G (IgG) levels were affected by the CORT treatment (P < 0.05); however, these factors were not significantly affected by the dietary energy level. Toll-like receptor-5 mRNA level was down-regulated by CORT injection in the duodenum and ileum (P < 0.05) and showed a trend of down-regulation in the jejunum (P=0.0846). The present study showed that CORT treatment induced immunosuppressive effects on the innate immune system of broiler chickens, which were ameliorated by consumption of higher dietary energy.


Subject(s)
Chickens/immunology , Corticosterone/pharmacology , Energy Intake , Animals , Chickens/blood , Chickens/genetics , Chickens/growth & development , Intestinal Mucosa/metabolism , Intestines/drug effects , Male , Organ Size/drug effects , Organ Size/immunology , Transcriptome/drug effects , Transcriptome/immunology
17.
PLoS One ; 9(11): e112472, 2014.
Article in English | MEDLINE | ID: mdl-25379804

ABSTRACT

The commensal yeast Candida albicans is part of the human intestinal microflora and is considered a "pathobiont", a resident microbe with pathogenic potential yet harmless under normal conditions. The aim of this study was to investigate the effect of C. albicans on inflammation of the intestinal tract and the role of Bruton's tyrosine kinase (Btk). Btk is an enzyme that modulates downstream signaling of multiple receptors involved in innate and adaptive immunity, including the major anti-fungal receptor Dectin-1. Colitis was induced in wild type and Btk-/- mice by treatment with dextran sodium sulfate (DSS) and the gastrointestinal tract of selected treatment groups were then colonized with C. albicans. Colonization by C. albicans neither dampened nor exacerbated inflammation in wild type mice, but colon length and spleen weight were improved in Btk-deficient mice colonized with C. albicans. Neutrophil infiltration was comparable between wild type and Btk-/- mice, but the knockout mice displayed severely reduced numbers of macrophages in the colon during both DSS and DSS/Candida treatment. Smaller numbers and reduced responsiveness of Btk-/- macrophages might partially explain the improved colon length of Btk-/- mice as a result of Candida colonization. Surprisingly, DSS/Candida-treated Btk-/- animals had higher levels of certain pro-inflammatory cytokines and levels of the anti-inflammatory cytokine TGF-ß were reduced compared to wild type. A clustering and correlation analysis showed that for wild type animals, spleen TGF-ß and colon IL-10 and for Btk-/- spleen and colon levels of IL-17A best correlated with the inflammatory parameters. We conclude that in Btk-/- immunocompromised animals, colonization of the gastrointestinal tract by the commensal yeast C. albicans alters inflammatory symptoms associated with colitis.


Subject(s)
Candida albicans/immunology , Candidiasis/immunology , Cytokines/immunology , Inflammation Mediators/immunology , Intestines/immunology , Protein-Tyrosine Kinases/immunology , Agammaglobulinaemia Tyrosine Kinase , Animals , Candida albicans/physiology , Candidiasis/metabolism , Candidiasis/microbiology , Colitis/genetics , Colitis/immunology , Colitis/microbiology , Colon/immunology , Colon/metabolism , Colon/pathology , Cytokines/metabolism , Dextran Sulfate/immunology , Host-Pathogen Interactions/immunology , Humans , Immunohistochemistry , Inflammation Mediators/metabolism , Interleukin-10/immunology , Interleukin-10/metabolism , Interleukin-17/immunology , Interleukin-17/metabolism , Intestinal Mucosa/metabolism , Intestines/microbiology , Macrophages/immunology , Macrophages/metabolism , Macrophages/microbiology , Mice, Knockout , Organ Size/immunology , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , Spleen/immunology , Spleen/metabolism , Spleen/pathology , Transforming Growth Factor beta/immunology , Transforming Growth Factor beta/metabolism
18.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 30(5): 509-12, 2014 May.
Article in Chinese | MEDLINE | ID: mdl-24796747

ABSTRACT

OBJECTIVE: To explore the protective effects of interleukin-17 monoclonal antibody (IL-17 mAb) on viral myocarditis (VMC) mice and its possible molecular mechanisms. METHODS: Ninety BALB/c mice were randomly divided into 4 groups: normal control group (n=15), model group (n=25), isotype control group (n=25) and IL-17 mAb group (n=25). Mice in model, isotype control and IL-17 mAb groups were inoculated with 0.1 mL Eagle's solution containing Coxsackievirus B3 (CVB3) intraperitoneally; and those in normal control group were treated with 0.1 mL Eagle's solution without CVB3. On the day 3 and 5 after inoculation, mice in isotype control and IL-17 mAb groups received intragastric administration of 100 µg non-specific IgG antibody and IL-17 mAb, respectively. On day 7 postinoculation, 5 mice were killed in each group, and the hearts were removed. Virus titer was detected using Reed-Muench method, and CVB3 mRNA copy number was measured by real-time quantitative PCR. All mice were killed on day 14 after weighing body mass (BM). The mortality was compared among groups. Serum was separated and serum cardiac troponin I (cTnI) concentration was detected using ELISA. The heart was removed and weighed to calculate heart index (HM/BM). Histological sections of heart were stained with hematoxylin-eosin and myocardial histopathologic scores were counted under optical microscope. The expression of nuclear factor-κB (NF-κB) p65 was examined by Western blotting. Myocardial interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels were detected by ELISA. RESULTS: The HM/BM, serum cTnI concentration, NF-κB p65 expression level and myocardial IL-6 and TNF-α contents in model group were higher than those in normal control group (P<0.01). In comparison with model and isotype control groups, mortality, HM/BM, serum cTnI concentration, myocardial histopathologic scores, virus titer, CVB3 mRNA copy number, NF-κB p65 expression level, and myocardial IL-6 and TNF-α contents in IL-17 mAb group were significantly reduced (P<0.05 or 0.01). There was no difference in the above indicators between isotype control group and model group(P>0.05). CONCLUSION: IL-17 mAb can improve myocardial injury in VMC mice, and the mechanisms are associated with the inhibition of viral replication and NF-κB activation.


Subject(s)
Antibodies, Monoclonal/pharmacology , Coxsackievirus Infections/prevention & control , Interleukin-17/immunology , Myocarditis/prevention & control , Animals , Antibodies, Monoclonal/immunology , Blotting, Western , Body Weight/drug effects , Body Weight/immunology , Coxsackievirus Infections/immunology , Coxsackievirus Infections/virology , Enterovirus B, Human/genetics , Enterovirus B, Human/immunology , Enterovirus B, Human/physiology , Gene Expression Regulation, Viral/immunology , Host-Pathogen Interactions/drug effects , Host-Pathogen Interactions/immunology , Interleukin-6/immunology , Interleukin-6/metabolism , Mice , Mice, Inbred BALB C , Myocarditis/immunology , Myocarditis/virology , Myocardium/immunology , Myocardium/metabolism , Myocardium/pathology , Organ Size/drug effects , Organ Size/immunology , Random Allocation , Reverse Transcriptase Polymerase Chain Reaction , Survival Analysis , Transcription Factor RelA/immunology , Transcription Factor RelA/metabolism , Troponin I/blood , Troponin I/immunology , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
19.
Int J Radiat Biol ; 90(7): 515-26, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24597753

ABSTRACT

PURPOSE: Concern regarding radiation effects on human health continues to increase worldwide. Given that infection is a major cause of morbidity and mortality after exposure, the aim of this study was to evaluate decrements in immune cell populations using a mammalian model subjected to a live bacterial infection. MATERIALS AND METHODS: C57BL/6 mice were exposed to total-body irradiation (TBI) with 3 Gy protons (70 cGy/min). One, 2, 4, 8 or 16 days later, subsets of mice were injected intraperitoneally with live Escherichia coli [055:K59(B5)]. Control groups received no radiation and vehicle (no bacteria). The mice were euthanized for analyses 90-120 min after injection of the bacteria. RESULTS: There were no unexpected effects of radiation or E. coli alone. Despite dramatic radiation-induced decreases in all leukocyte populations in both the blood and spleen, irradiated mice were still able to respond to an immune challenge based on capacity to generate an oxidative burst and secrete inflammatory cytokines, i.e., tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). However, these responses were generally elevated above control values. CONCLUSIONS: Together, these results suggest the possibility for enhanced inflammation-associated tissue injury and increased risk for chronic inflammation.


Subject(s)
Escherichia coli/physiology , Microbial Viability , Whole-Body Irradiation/adverse effects , Animals , Body Size/immunology , Body Size/radiation effects , Cytokines/metabolism , Dose-Response Relationship, Radiation , Erythrocyte Count , Female , Gene Expression Regulation/immunology , Gene Expression Regulation/radiation effects , Histocompatibility Antigens Class II/metabolism , Leukocytes/cytology , Leukocytes/immunology , Leukocytes/radiation effects , Mice , Mice, Inbred C57BL , Organ Size/immunology , Organ Size/radiation effects , Platelet Count , Respiratory Burst/immunology , Respiratory Burst/radiation effects , Spleen/cytology , Spleen/immunology , Spleen/radiation effects
20.
Res Vet Sci ; 96(2): 260-6, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24508082

ABSTRACT

In recent years, co-infection of chicken embryos with immunosuppressive viruses and bacteria occurs with an annually increasing frequency. Consequently, studies on new and safe immunoregulators, especially plant polysaccharides, have become a popular topic in the poultry industry. In the present study, we selected 300 specific pathogen free embryonated eggs, which were injected with subgroup B avian leukosis virus (ALV-B) and Bordetella avium (B. avium) to establish an artificial co-infection model. The chicks that hatched from these co-infected embryonated eggs were treated with Taishan Pinus massoniana pollen polysaccharide (TPPPS). Results indicated that relevant indices in the co-infection group were significantly lower than that in B. avium-only group. Furthermore, pathogenicity of B. avium was exacerbated, with the chicks exhibiting decreased body weights. The TPPPS groups exhibited gradual improvements in immune function and developmental status. Therefore, in terms of improving immunologic function and production performance, TPPPS could be used as immunoregulator for immune responses.


Subject(s)
Avian Leukosis Virus/immunology , Avian Leukosis/complications , Bordetella Infections/veterinary , Bordetella avium/immunology , Chickens , Poultry Diseases/microbiology , Poultry Diseases/virology , Animals , Antibodies, Bacterial/blood , Avian Leukosis/immunology , Avian Leukosis/virology , Body Weight/immunology , Bordetella Infections/complications , Bordetella Infections/immunology , Bordetella Infections/microbiology , Chick Embryo , Interferon-gamma/blood , Interleukin-2/blood , Organ Size/immunology , Pinus/immunology , Polysaccharides/immunology , Polysaccharides/therapeutic use , Poultry Diseases/immunology , Random Allocation , Specific Pathogen-Free Organisms , Viremia/veterinary , Viremia/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...